Skip to main content

GOLDMAN SACHS GROUP INC

Position in SMMT — Summit Therapeutics Inc.

CIK 886982 NEW YORK, NY

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$65,760,223
+$59,868,821 QoQ
Shares Held
4,513,399
+1352.5% QoQ
Ownership
0.566%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 242 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Jun 30, 2025
CallValue
$832,048
CallShares
39,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. SMMT ranks #53 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SMMT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $65,760,223 4,513,399
2026-03-31 $5,891,402 310,728
2025-12-31 $8,492,548 485,566
2025-09-30 $10,279,320 497,547
2025-06-30 $6,456,904 303,426
2025-06-30 $832,048 39,100
2025-03-31 $754,239 39,100
2025-03-31 $11,049,137 572,791
2024-12-31 $16,238,985 910,002
2024-09-30 $10,848,273 495,355
2024-09-30 $797,160 36,400
2024-06-30 $3,540,763 453,944
2024-03-31 $2,817,687 680,601
2023-12-31 $507,404 194,408
2023-09-30 $359,409 192,198
2023-06-30 $881,014 351,002
2023-03-31 $771,555 440,889
2022-12-31 $235,921 55,511
2022-09-30 $72,280 60,740
2022-06-30 $34,393 34,393
2022-03-31 $90,103 36,777
2021-12-31 $126,671 47,090
2021-09-30 $208,185 41,554
2021-06-30 $303,539 40,689
2021-03-31 $507,807 86,509
2020-12-31 $163,602 34,809